secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001564590-22-039439
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO transition: Caren Mason retires, Tom Frinzi appointed; Q4 net sales guidance $64M-$66M
--------------------------------------------------------------------------------

- CEO Caren Mason retires Dec 31, 2022; Board Chair Tom Frinzi becomes CEO effective Jan 1, 2023.
- Mason to serve as advisor through Dec 2023 at $100k/month and eligible for 2022 cash bonus.
- Frinzi receives $820k base salary, 105% target bonus, and $9M initial equity grant (options & RSUs).
- Board reduces to 6 members; Stephen Farrell named Lead Independent Director effective Jan 1, 2023.
- Company expects Q4 2022 net sales in the range of $64M to $66M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/0001564590-22-039439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/staa-8k_20221216.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-039439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer